Dabucon, Nereka M.
HRN: 25-35-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/04/2024
07/04/2024
IV
Stat
Stat
For IJ Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes